Importance of Patient Capital in Life Sciences
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
At the MedCity INVEST conference this week, a panel discussion highlighted the benefits of going public in Canada as an alternative path for young growth stage companies to raise capital.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Register for MedCity INVEST at the Ritz Carlton in Chicago and be part of the conversation on healthcare investment trends. Attendees will also be able to take part in networking opportunities and hear health tech, medtech and pharma tech startups pitch to investors.